ALLR Allarity Therapeutics Inc

3,724

$0.5612

$0.0732

(15.00%)

Today

Market Cap	$2.35M
Volume (M)	4.98M
52-Wk High	$1,890.00
52-Wk Low	$0.401

ST Data

Watchers

New Watcher Rank

Fundamentals

Allarity's Early Phase 2 Stenoparib Data Indicates Clinical Benefit in Women with Advanced Ovarian Cancer Selected with DRP Companion DiagnosticGlobe Newswire • 5 days ago

All evaluable participants, with prior PARP inhibitor therapy and chemotherapy, showed significant tumor shrinkage including one complete response Early data follows Phase 2 dose optimization change...

Share to Feed

Allarity Therapeutics files for $50M mixed shelfSeekingAlpha.com: All News • about 1 month ago

Allarity Therapeutics files for $50M mixed shelf...

Allarity Therapeutics (NASDAQ:ALLR) Shares Up 4%Zolmax • about 2 months ago

Allarity Therapeutics, Inc. (NASDAQ:ALLR Get Free Report)s stock price shot up 4% during mid-day trading on Wednesday . The stock traded as high as $0.73 and last traded at $0.73...

Allarity Therapeutics to Present at Biomarkers Europe 2023Globe Newswire • 2 months ago

Allarity will present on development of several drug-specific DRP companion diagnostics, and participate in a panel discussion with speakers from Merck and Roche BOSTON, October 2, 2023 Allarity...

Allarity Therapeutics Gaining Momentum? Hits Multiple Milestones Including Positive Publications In PLOS One And At ASCO, Positive Early Data From An Ongoing Clinical Trial, And External Partnering For Its DRP(R) TechnologyAccesswire • 3 months ago

CAMBRIDGE, MA / ACCESSWIRE / September 14, 2023 / Allarity Therapeutics (NASDAQ:ALLR) is a biotechnology company focused on realizing true personalized cancer care by developing targeted cancer...

Thinking about buying stock in Allarity Therapeutics, Better Home & Finance Holding, Top KingWin, Axcella Health, or Metatron Apps?PR Newswire • 3 months ago

Thinking about buying stock in Allarity Therapeutics, Better Home & Finance Holding, Top KingWin, Axcella Health, or Metatron Apps? Thinking about buying stock in Allarity Therapeutics, Better Home & Finance Holding, Top KingWin, Axcella Health, or Metatron Apps? PR Newswire NEW...

PLOS ONE Publishes Data on Allarity Therapeutics' DRP(R) Companion Diagnostic for DovitinibGlobe Newswire • 3 months ago

- The DRP-Dovitinib companion diagnostic demonstrated an ability to identify advanced renal cell carcinoma patients that have improved clinical benefit from dovitinib treatment, as compared to unselected patients BOSTON (August 30, 2023) Allarity Therapeutics, Inc. (Allarity or the Company) (Nasdaq...

Allarity Therapeutics, Inc. (NASDAQ:ALLR) Sees Large Increase in Short InterestTicker Report • 3 months ago

Allarity Therapeutics, Inc. (NASDAQ:ALLR Get Free Report) was the recipient of a large growth in short interest in the month of August. As of August 15th, there was short interest totalling...

Thinking about buying stock in Oncolytics Biotech, INVO Bioscience, Troika Media Group, Allarity Therapeutics, or Barnes & Noble Education?PR Newswire • 4 months ago

Thinking about buying stock in Oncolytics Biotech, INVO Bioscience, Troika Media Group, Allarity Therapeutics, or Barnes & Noble Education? Thinking about buying stock in Oncolytics Biotech, INVO Bioscience, Troika Media Group, Allarity Therapeutics, or Barnes & Noble Education? PR...

Short Interest in Allarity Therapeutics, Inc. (NASDAQ:ALLR) Rises By 176.3%Ticker Report • 4 months ago

Allarity Therapeutics, Inc. (NASDAQ:ALLR Get Free Report) saw a large increase in short interest during the month of July. As of July 15th, there was short interest totalling 63,000 shares, an increase of 176.3% from the June 30th total of 22,800 shares. Based on an average trading volume of...